NON-MUSCLE-INVASIVE UROTHELIAL CARCINOMA

Clinical trials for NON-MUSCLE-INVASIVE UROTHELIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new NON-MUSCLE-INVASIVE UROTHELIAL CARCINOMA trials appear

Sign up with your email to follow new studies for NON-MUSCLE-INVASIVE UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Targeted pill tested for Tough-to-Treat bladder tumors

Disease control Completed

This small pilot study tested whether an oral drug called BGJ398 could shrink tumors in patients with a specific type of recurrent bladder cancer. It involved 4 adults whose cancer had returned after standard treatment and who had a particular genetic mutation. The goal was to se…

Matched conditions: NON-MUSCLE-INVASIVE UROTHELIAL CARCINOMA

Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

NON-MUSCLE-INVASIVE UROTHELIAL CARCINOMA

Get alerted when new NON-MUSCLE-INVASIVE UROTHELIAL CARCINOMA trials appear

Targeted pill tested for Tough-to-Treat bladder tumors